FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称DAPAGLIFLOZIN
异名/同义词(2S,3R,4R,5S,6R)-2-(4-CHLORO-3-(4-ETHOXYBENZYL)PHENYL)-6-(HYDROXYMETHYL)TETRAHYDRO-2H-PYRAN-3,4,5-TRIOL
BMS-512148
BR1019 COMPONENT DAPAGLIFLOZIN
DAPAGLIFLOZIN
DAPAGLIFLOZIN [INN]
DAPAGLIFLOZIN [MI]
DAPAGLIFLOZIN [ORANGE BOOK]
DAPAGLIFLOZIN [USAN]
DAPAGLIFLOZIN [VANDF]
DAPAGLIFLOZIN [WHO-DD]
DAPAGLIFLOZIN COMPONENT QTERNMET
D-GLUCITOL, 1,5-ANHYDRO-1-C-(4-CHLORO-3-((4-ETHOXYPHENYL)METHYL)PHENYL)-, (1S)-
LYN-045
QTERNMET COMPONENT DAPAGLIFOZIN
QTERNMET XR COMPONENT DAPAGLIFLOZIN
CAS登记号461432-26-8
物质唯一标识(Unique Ingredient Identifier)1ULL0QJ8UC
分子式C21H25ClO6
国际化合物标识(International Chemical Identifier,InChI)JVHXJTBJCFBINQ-ADAARDCZSA-N
SMILES[C@H]1([C@H]([C@@H]([C@H]([C@H](c2cc(c(cc2)Cl)Cc3ccc(OCC)cc3)O1)O)O)O)CO
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System